Long-term exposure to high levels of the adrenocorticotropic hormone (ACTH) may lead to a recurrence of Cushing’s disease even after…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
Corcept Therapeutics has received notice that it will be issued a new patent in the U.S. covering the use of…
Mutations in USP48 and BRAF genes contribute to the overproduction of adrenocorticotropin (ACTH) hormone by the pituitary gland and…
A study examining the genes expressed in pituitary tumors of Cushing’s disease patients found that these tumors may be grouped…
Cushing’s syndrome patients who have adrenal insufficiency have increased risk of death due to disease-related complications, rather than adrenal crisis…
Cushing’s Patients at Risk of Life-threatening Pulmonary Fungal Infection, Case Studies Suggest
Cushing’s disease patients who exhibit nodules or masses in their lungs should be thoroughly investigated to exclude fungal infection with Cryptococcus…
Children with pituitary adenomas have similar responses to surgery and long-term outcomes as adult patients with the same type of…
Researchers have identified several parameters that could help distinguish silent corticotroph adenomas — benign pituitary tumors that produce adrenocorticotropic hormone…
Signifor LAR Shows Long-term Benefits for Cushing’s Disease Patients in Phase 3 Extension Trial
Long-term treatment with Signifor LAR, a long-acting formulation of pasireotide, effectively reduced pituitary tumor volume and improved symptoms…
To help improve the effectiveness of surgical treatment of Cushing’s disease, researchers conducted a study to determine common failures. They…